N. Wagle

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.

E. Winer, L. Carey, J. Garber, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic Breast Cancer

A. DeMichele, H. Burstein, K. Miller, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial

R. Barroso-Sousa, S. Tolaney, Jorge Gómez Tejeda Zañudo, 2024, Nature communications.